As of 2025-12-29, the Relative Valuation of Oncternal Therapeutics Inc (ONCT) is (212.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.53 USD, the upside of Oncternal Therapeutics Inc based on Relative Valuation is -40359.3%.
The range of the Relative Valuation is (171.01) - (228.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 19.5x | 18.0x |
| Forward P/E multiples | 14.6x - 22.0x | 18.3x |
| Fair Price | (171.01) - (228.01) | (212.01) |
| Upside | -32573.6% - -43398.2% | -40359.3% |
| Date | P/E |